NCI NewsCenter
NCI Budget Data
Visuals Online
NCI Fact Sheets
Understanding Cancer SeriesRichard Fagerstrom, Ph.D., an NCI mathematical statistician from the Division of Cancer Prevention, was the co-chief statistician for the National Lung Screening Trial, a nearly decade-long study that showed a 20 percent reduction in lung mortality among heavy smokers screening with low-dose CT, compared to those screened with X-ray. In this interview from June 2011, Fagerstrom discusses the trial, from concept design to primary results.
Articles Posted in ‘Scientist Spotlight’
Kramer explains results of the PLCO trial
August 14, 2012, 4:16PM
Barnett Kramer, M.D., M.P.H, directs NCI’s Division of Cancer Prevention. In May 2012, he sat down to explain the results of the Prostate, Lung, Colorectal and Ovarian Cancer Trial, the largest cancer screening trial ever performed in the United States. The four common cancers studied collectively account for almost 45 percent of cancer-related deaths in the U.S.
Staudt discusses Lymphoma research
August 14, 2012, 4:10PM
Louis Staudt, M.D., Ph.D., is the deputy chief of the Metabolism Branch in NCI’s Center for Cancer Research. In this video from March 2012, Staudt discusses the basic biology of targeted therapy for Diffuse B-cell Lymphoma and about ibrutinib, a drug with a high degree of efficacy—and only modest side effects—in the treatment of the ABC form of Diffuse B-cell Lymphoma.